|
a. Cytoplasm |
||
|
b. Tissue |
||
|
c. Neoplasm |
||
|
d. Oncogene |
|
a. Size |
||
|
b. Growth pattern |
||
|
c. Location of origin |
||
|
d. Appearance |
|
a. Invasive |
||
|
b. Benign |
||
|
c. Metastatic |
||
|
d. Apoptotic |
|
a. Studying yeast cell cultures |
||
|
b. Conducting experiments using mice |
||
|
c. Researching basic cell biology |
||
|
d. All of the above |
|
a. Describing the chemical structure of DNA |
||
|
b. Outlining how cancer spreads |
||
|
c. Identifying mutations that cause cancer |
||
|
d. Establishing guidelines for cancer therapy |
|
a. Carcinoma |
||
|
b. Sarcoma |
||
|
c. Lymphoma |
||
|
d. Leukemia |
|
a. Incurability |
||
|
b. Loss of growth control |
||
|
c. Origination in lymph |
||
|
d. Contagiousness |
|
a. He explained cancer development with autopsy findings. |
||
|
b. He correlated cancer progression to microscopy findings. |
||
|
c. He described the humoral theory. |
||
|
d. He thought that cancer cells came from lymph. |
|
a. When new cells are being formed faster than needed |
||
|
b. When cell death surpasses cell division (growth) |
||
|
c. When cell division equals cell death |
||
|
d. When cells no longer divide |
|
a. It was the first induced in lab animals. |
||
|
b. It was the first known to be caused by a virus. |
||
|
c. It developed because of the carcinogen tobacco. |
||
|
d. It was caused by coal tar. |
|
a. The theory that cancer is infectious is well established and proven true. |
||
|
b. The theory that cancer is infectious led cancer patients years ago to be housed in the city near other people including doctors. |
||
|
c. The theory that cancer is infectious was based on several members of the same household contracting breast cancer. |
||
|
d. The theory that cancer is infectious explains how cancer cells spread within a person. |
|
a. He described cancer as curable. |
||
|
b. He did not believe in cancer. |
||
|
c. He thought that cancer was incurable. |
||
|
d. He outlined cancer treatments. |
|
a. He developed anesthesia. |
||
|
b. He performed autopsies. |
||
|
c. He did radical mastectomies. |
||
|
d. He explained that some tumors can be removed. |
|
a. Celsus |
||
|
b. Hunter |
||
|
c. Hippocrates |
||
|
d. House |
|
a. Adenine |
||
|
b. Guanine |
||
|
c. Cytosine |
||
|
d. Thymine |
|
a. Thymine dimers |
||
|
b. Frameshift mutations |
||
|
c. Insertions |
||
|
d. Chromosome breaks |
|
a. Mismatch repair |
||
|
b. Proofreading |
||
|
c. Recombination |
||
|
d. Apoptosis |
|
a. Protein |
||
|
b. Nucleic acid |
||
|
c. Carbohydrate |
||
|
d. Lipid |
|
a. Nucleic acids |
||
|
b. Amino acids |
||
|
c. Monosaccharides |
||
|
d. Lipids |
|
a. Five |
||
|
b. Three |
||
|
c. Four |
||
|
d. Two |
|
a. One |
||
|
b. Two |
||
|
c. Three |
||
|
d. Four |
|
a. Create thymine dimers |
||
|
b. Develop base substitutions |
||
|
c. Have a frameshift mutation |
||
|
d. Exchange adenine for guanine |
|
a. Sucrose |
||
|
b. Deoxyribose |
||
|
c. Ribose |
||
|
d. Fructose |
|
a. To transfer phosphates |
||
|
b. To remove phosphates |
||
|
c. To bind to ligands |
||
|
d. To block receptor binding |
|
a. mRNA |
||
|
b. tRNA |
||
|
c. rRNA |
||
|
d. sRNA |
|
a. No further mutations occur. |
||
|
b. There will be no impact on DNA. |
||
|
c. DNA mutations will accumulate. |
||
|
d. Only repair proteins will be impacted. |
|
a. Cytoplasm |
||
|
b. Mitochondria |
||
|
c. Nucleus |
||
|
d. Cell membrane |
|
a. Tumor suppressors |
||
|
b. Oncogenes |
||
|
c. Proto-oncogenes |
||
|
d. DNA repair genes |
|
a. Ligand |
||
|
b. GTP |
||
|
c. Adenylyl cyclase |
||
|
d. cAMP |
|
a. Differentiation |
||
|
b. The production of hormones |
||
|
c. Proliferation of cells |
||
|
d. Both A and C |
|
a. Src |
||
|
b. p53 |
||
|
c. BRCA-1 |
||
|
d. Rb |
|
a. Ligands enter the cell and elicit their effect. |
||
|
b. The receptor changes conformation and directly causes DNA transcription. |
||
|
c. The signaling event is amplified inside the cell. |
||
|
d. Signal transduction cascades run indefinitely. |
|
a. Beta pleated sheet |
||
|
b. Double helix |
||
|
c. Single spiral |
||
|
d. Hexagonal plane |
|
a. By transferring a phosphate |
||
|
b. By removing a methyl group |
||
|
c. By binding to receptor on cell surface |
||
|
d. By targeting DNA for transcription |
|
a. G1 |
||
|
b. S |
||
|
c. G2 |
||
|
d. M |
|
a. Chromosomes line up in the center of the cell. |
||
|
b. DNA is replicated. |
||
|
c. The nuclear membrane disappears. |
||
|
d. Proteins pull apart the chromosomes. |
|
a. It is a type of eye cancer. |
||
|
b. It is a transcription factor. |
||
|
c. It is a tumor suppressor. |
||
|
d. All of the above |
|
a. Oncogenes |
||
|
b. Tumor suppressors |
||
|
c. DNA repair genes |
||
|
d. Accessory proteins |
|
a. Myc |
||
|
b. p53 |
||
|
c. Src |
||
|
d. Rb |
|
a. Myc |
||
|
b. p53 |
||
|
c. Src |
||
|
d. Rb |
|
a. G1/S |
||
|
b. S/G2 |
||
|
c. G2/M |
||
|
d. Metaphase/anaphase transition |
|
a. Cyclins |
||
|
b. Cyclin dependent kinases |
||
|
c. Tumor suppressors |
||
|
d. Oncogenes |
|
a. Inactivation of tumor suppressors |
||
|
b. Mutations of DNA repair genes |
||
|
c. Conversion of proto-oncogenes to oncogenes |
||
|
d. All of the above |
|
a. BRCA1 or BRCA2 testing is used to diagnose breast cancer. |
||
|
b. BRCA1 or BRCA2 testing screens for an increased risk of developing breast cancer. |
||
|
c. BRCA1 or BRCA2 testing is easily interpreted. |
||
|
d. BRCA1 or BRCA2 testing is useful for patients that have breast cancer. |
|
a. Myc |
||
|
b. Src |
||
|
c. p53 |
||
|
d. Bcl-2 |
|
a. G1 |
||
|
b. S |
||
|
c. G2 |
||
|
d. M |
|
a. Hyperplasia |
||
|
b. Dysplasia |
||
|
c. Anaplasia |
||
|
d. Carcinoma in situ |
|
a. Breast |
||
|
b. Cervix |
||
|
c. Liver |
||
|
d. Lung |
|
a. Dysplasia |
||
|
b. Carcinoma in situ |
||
|
c. Hyperplasia |
||
|
d. Anaplasia |
|
a. To develop a polio vaccine |
||
|
b. To study genetics |
||
|
c. To conduct numerous scientific studies |
||
|
d. All of the above |
|
a. Stimulate death receptor clustering |
||
|
b. Directly target caspase |
||
|
c. Block lipid raft fusion |
||
|
d. Turn off the process of apoptosis |
|
a. 4 months |
||
|
b. 3 days |
||
|
c. 2 weeks |
||
|
d. 1 hour |
|
a. It progresses. |
||
|
b. It is arrested. |
||
|
c. It takes twice as long. |
||
|
d. It requires p53. |
|
a. Ionizing radiation |
||
|
b. Depletion of growth factors and nutrients needed to survive |
||
|
c. Infection of the cell by a virus |
||
|
d. All of the above |
|
a. Binding of B lymphocytes to death receptors |
||
|
b. Signals from the mitochondria |
||
|
c. Granzyme |
||
|
d. Caspase |
|
a. p53 |
||
|
b. Myc |
||
|
c. IGF |
||
|
d. Bcl-2 |
|
a. Caspase |
||
|
b. p53 |
||
|
c. Telomerase |
||
|
d. Ras |
|
a. It comes before initiation. |
||
|
b. It does not require initiation. |
||
|
c. More promoters will lead to a more pronounced risk. |
||
|
d. Low levels of promoters will not likely cause tumor promotion. |
|
a. Sarcomas |
||
|
b. Carcinomas |
||
|
c. Blastomas |
||
|
d. All of the above |
|
a. Telomeres are replaced. |
||
|
b. Telomeres are removed. |
||
|
c. Telomeres lengthen. |
||
|
d. Telomeres shorten. |
|
a. Necrosis |
||
|
b. Apoptosis |
||
|
c. Replication |
||
|
d. Mutation |
|
a. Stimulate growth factors. |
||
|
b. Induce angiogenesis. |
||
|
c. Build the basement membrane. |
||
|
d. Destroy extracellular matrix (ECM). |
|
a. Oncogenesis |
||
|
b. Metastasis |
||
|
c. Angiogenesis |
||
|
d. Anaplasia |
|
a. Adrenal |
||
|
b. Lung |
||
|
c. Liver |
||
|
d. Renal |
|
a. Heart |
||
|
b. Lungs |
||
|
c. Liver |
||
|
d. Cervix |
|
a. Adhesion molecules |
||
|
b. The absence of growth factors |
||
|
c. The blood vessel size supplying that tissue |
||
|
d. Platelets |
|
a. Breast |
||
|
b. Lung |
||
|
c. Blood |
||
|
d. Colon |
|
a. VEGF |
||
|
b. bFGF |
||
|
c. Endostatin |
||
|
d. p53 |
|
a. In the blood |
||
|
b. In the lymphatic system |
||
|
c. Through body walls |
||
|
d. Via the gastrointestinal tract |
|
a. VEGF |
||
|
b. p53 |
||
|
c. Ras |
||
|
d. BRCA1 |
|
a. Everyone has slightly different lymphatic networks. |
||
|
b. More cells are found in lymph than in blood, making it hard to spot cancer cells. |
||
|
c. Tumor cells do not interact with the lymphatic vessels. |
||
|
d. Lymph nodes hide cancer cells, making it difficult to detect them there. |
|
a. Angiogenesis |
||
|
b. Oncoprogression |
||
|
c. Hitching |
||
|
d. Metastasis |
|
a. An initiator |
||
|
b. An inducer |
||
|
c. A promoter |
||
|
d. Both A and C |
|
a. Proliferation |
||
|
b. Biotransformation |
||
|
c. Promotion |
||
|
d. Induction |
|
a. In an animal model |
||
|
b. In a single concentration |
||
|
c. In isolation |
||
|
d. At high rates of speed |
|
a. Cervical |
||
|
b. Endometrial |
||
|
c. Breast |
||
|
d. Bladder |
|
a. Genetics |
||
|
b. Environmental factors |
||
|
c. Nutritional status |
||
|
d. Older age |
|
a. 1 |
||
|
b. 2A |
||
|
c. 2B |
||
|
d. 3 |
|
a. Time of exposure |
||
|
b. Potency |
||
|
c. Dose-response |
||
|
d. All of the above |
|
a. Literacy |
||
|
b. Race |
||
|
c. Gender |
||
|
d. Income |
|
a. UV radiation |
||
|
b. Oxygen free radicals |
||
|
c. Genetics |
||
|
d. Viruses |
|
a. Smoking |
||
|
b. Asbestos |
||
|
c. Radon |
||
|
d. Arsenic |
|
a. Aflatoxins |
||
|
b. Benzene |
||
|
c. Hepatitis B and C viruses |
||
|
d. Alcohol |
|
a. Breast |
||
|
b. Lung |
||
|
c. Colorectal |
||
|
d. Prostate |
|
a. Breast cancer |
||
|
b. Colon cancer |
||
|
c. Cervical cancer |
||
|
d. Lung cancer |
|
a. 35 |
||
|
b. 45 |
||
|
c. 40 |
||
|
d. 50 |
|
a. No later than 21 |
||
|
b. 30 |
||
|
c. Before 21 if sexually active |
||
|
d. Both A and C |
|
a. Microarray |
||
|
b. Mammogram |
||
|
c. Biopsy |
||
|
d. Oncogram |
|
a. Metastasis |
||
|
b. Loss of cell growth |
||
|
c. Patient’s chance of survival |
||
|
d. Risk for secondary infection |
|
a. UV radiation |
||
|
b. Tobacco smoking |
||
|
c. Radioisotopes |
||
|
d. Genetics |
|
a. Sarcoma |
||
|
b. Blastoma |
||
|
c. Carcinoma |
||
|
d. Melanoma |
|
a. Breast cancer |
||
|
b. Cervical cancer |
||
|
c. Prostate cancer |
||
|
d. Colon cancer |
|
a. Eat a high fiber diet |
||
|
b. Exercise daily |
||
|
c. Avoid tobacco |
||
|
d. Have an annual check-up |
|
a. Environmental exposure |
||
|
b. Genetic predisposition |
||
|
c. Dietary intake |
||
|
d. Medical status |
|
a. Tobacco |
||
|
b. Poor diet |
||
|
c. Alcohol |
||
|
d. Both A and C |
|
a. Pap |
||
|
b. Mammogram |
||
|
c. PSA |
||
|
d. Fecal occult blood |
|
a. Pap |
||
|
b. Mammogram |
||
|
c. PSA |
||
|
d. Fecal occult blood |
|
a. Screening methods provide a definitive diagnosis. |
||
|
b. Screening methods are used to detect cancer in patients without symptoms. |
||
|
c. Screening methods should only be used if a patient has cancer symptoms. |
||
|
d. Screening methods have not made a significant impact on cancer prognosis. |
|
a. They mark cancer cells to be killed. |
||
|
b. They block important receptors on cancer cells. |
||
|
c. They carry toxic substances to the cancer cells. |
||
|
d. Both A and C |
|
a. Radiation |
||
|
b. Immunotherapy |
||
|
c. Chemotherapy |
||
|
d. Both A and C |
|
a. Methotrexate |
||
|
b. Doxil |
||
|
c. Mustard gas |
||
|
d. Avastin |
|
a. Chronic myelogenous leukemia |
||
|
b. Lymphoma |
||
|
c. Kaposi’s Sarcoma |
||
|
d. Acute colon cancer |
|
a. Cells lining the gastrointestinal track |
||
|
b. Cancer cells |
||
|
c. Bone marrow cells |
||
|
d. Skeletal muscle cells |
|
a. Inducing apoptosis |
||
|
b. Cell division |
||
|
c. Cancer cell proliferation |
||
|
d. Signaling |
|
a. Spindle promoter |
||
|
b. Antimetabolite |
||
|
c. Genotoxic agent |
||
|
d. Purine and pyrimidine antagonists |
|
a. Kinase inhibitor |
||
|
b. Angiogenesis inhibitor |
||
|
c. Antimetabolites |
||
|
d. Antisense oligonucleotides |
|
a. It is toxic to normal cells. |
||
|
b. The same siRNA cannot be used a second time if cancer returns. |
||
|
c. It is impossible to get siRNA into cells. |
||
|
d. siRNA stimulates an immune response. |
|
a. Lentivirus |
||
|
b. Adenovirus |
||
|
c. Herpes simplex virus |
||
|
d. Epstein Barr Virus |
|
a. To repair damaged tissues |
||
|
b. For long term maintenance |
||
|
c. To divide into tissue that will form organs |
||
|
d. To complete body tissues |
|
a. Esophagus |
||
|
b. Lung |
||
|
c. Prostate |
||
|
d. Colon |